share_log

Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SOBECKI CHRISTOPHER J

SEC announcement ·  Apr 29 16:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more